Rekha Aryal
Family · Chapel Hill, NCNPI 1558013508
Payments from drug & device makers
Across 25 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$64
- AbbVie$48
- Lilly USA, LLC$40
- AstraZeneca$34
- Takeda Pharmaceuticals U.S.A., Inc.$31
- Astellas Pharma US Inc$30
- plus $166 from 9 others
What the payments were for
- Food & beverage$413100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 4 | $64 |
| AbbVie | 3 | $48 |
| Lilly USA, LLC | 2 | $40 |
| AstraZeneca | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $30 |
| Shield Therapeutics Inc | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
| Corcept Therapeutics | 1 | $17 |
| Pfizer | 1 | $16 |
| Amgen | 1 | $15 |
| GSK | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Bayer | 1 | $13 |
How this compares
$413 in reported general payments places this provider in the 50th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 13 | $714 |
| Rosuvastatin Calcium | 24 | $309 |
| Levothyroxine Sodium | 19 | $140 |
| Gabapentin | 12 | $102 |
| Alendronate Sodium | 24 | $69 |
| Metformin Hcl | 15 | $42 |
| Pantoprazole Sodium | 14 | $41 |
| Amlodipine Besylate | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other family in Chapel Hill
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
- Debra ScottCharlotte$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.